Lupin acquires Japanese injectables maker

18 Nov 2011 Evaluate

Mumbai-based Lupin Ltd will acquire Tokyo-based I’rom Pharmaceuticals (IP) for an undisclosed amount to expand its footprint in the country. Kyowa Pharmaceutical, the Japanese subsidiary of Lupin, will acquire 100 % shares of the company and its annual sales for the year ended March 2011 was 5.36 billion yen ($69.7 million). Based out of Tokyo, IP specialises in supplying injectables to the reimbursement hospital segment, known as DPC. There are currently over 1,400 DPC hospitals in Japan, covering 35 per cent of all hospital beds nationwide, and a market size of $11-billion.  IP’s strong presence in the DPC hospital segment in Japan, through its line of injectable products, is an ideal fit with the company’s existing oral business portfolio in Japan.

Lupin Share Price

1581.65 -6.25 (-0.39%)
03-Jun-2024 14:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1463.35
Dr. Reddys Lab 5790.95
Cipla 1447.65
Zydus Lifesciences 1032.00
Lupin 1581.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.